U-Blot® Research Grade BudoprutugCat. No. WA2560$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade BudoprutugCat. No. WA2560
U-Blot® Research Grade BudigalimabCat. No. WA2559
U-Blot® Research Grade BrontictuzumabCat. No. WA2558
U-Blot® Research Grade BrolucizumabCat. No. WA2557
U-Blot® Research Grade BrodalumabCat. No. WA2556
U-Blot® Research Grade brivestobartCat. No. WA2555
U-Blot® Research Grade BrivekimigCat. No. WA2554
U-Blot® Research Grade BriquilimabCat. No. WA2553
U-Blot® Research Grade BriobaceptCat. No. WA2552
U-Blot® Research Grade BriakinumabCat. No. WA2551
U-Blot® Research Grade BrentuximabCat. No. WA2550
U-Blot® Research Grade BrenetafuspCat. No. WA2549